BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Related Posts
CopilotKit raises $27M to help devs deploy app-native AI agents
The Seattle-based startup’s Series A round was led by Glilot Capital, NFX and SignalFire, TechCrunch has exclusively learned.
Coby Adcock’s Scout AI raises $100 million to train its models for war. We visited its bootcamp.
We visited Scout AI’s training ground where it’s working on AI agents that give individual soldiers control of…
Agile Robots becomes the latest robotics company to partner with Google DeepMind
Agile Robots will incorporate Google DeepMind’s robotics foundation models into its bots while collecting data for the AI…
